The authors characterized the clinical features of patients with direct immunofluorescence (DIF)-negative mucous membrane pemphigoid (MMP). Source: AAO
This week, scientists inject a CRISPR-based treatment into a human eye, a novel contact lens shows promise for red-green color blindness and a biologic eye drop for ocular graft-versus-host disease snags orphan drug status. Source: AAO
Allergan’s bimatoprost implant (Durysta) is now the first approved intracameral, sustained-release therapy for lowering IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO
This prospective, observational case series evaluated the severity of macular vascular changes in children with sickle cell disease. Source: AAO
The authors analyzed the proportion of females presenting at 9 major ophthalmology conferences over a 3-year period. Source: AAO
This systematic review evaluated evidence relating to 3 different autologous limbal stem cell transplantation (LSCT) techniques. Source: AAO
This prospective clinical trial compared the long-term safety and efficacy of amniotic membrane-umbilical cord and pericardium patch grafts for reducing glaucoma shunt tube exposure. Source: AAO
This week, surgeons discover a Phillips-head screw buried under a woman’s retina, a novel implant bypasses the eyes to restore vision and researchers share updates on a stem cell and gene therapies for retinitis pigmentosa. Source: AAO
This study evaluated adjuvant corneal crosslinking (CXL) for treatment of filamentous fungal keratitis. Source: AAO
Novartis has launched a safety review of their new anti-VEGF agent brolucizumab (Beovu) following reports of possible unintended side effects after the drug was approved last October. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
